Featured

Status

Health Topics

Any Category
Diseases
Neoplasms
Clear Filters

Search Clinical Trials

101 Results
Completed
MTD Study of Vaccine BP-GMAX-CD1 Plus AP1903 to Treat Castrate Resistant Prostate Cancer
Patients will be screened within 6 weeks prior to Week 1. A total of 3 cohorts, consisting of 3 to 6 patients each, are planned to receive five to eight …
Baylor Role: Collaborator
Completed
Health-Related Quality of Life in Gay Men With Localized Prostate Cancer
OBJECTIVES: - To enroll 200 gay men with localized prostate cancer in a cross-sectional study of prostate cancer outcomes. - To complete an R01 application using pilot data collected from …
Baylor Role: Lead Sponsor
Terminated
Genetic Susceptibility to Kidney Cancer
This study will further the understanding of the genetic events leading to the development of RCC; explore the genetic basis for genetic instability and how it affects cancer risk; and …
Baylor Role: Lead Sponsor
Completed
Evaluating Symptom Management Educational Materials for Patients With Prostate Cancer
OBJECTIVES: - To collect formative evaluation data about a new educational intervention using focus groups of patients with prostate cancer. - To use the focus group data in the master's …
Baylor Role: Lead Sponsor
Completed
Health-Related Quality of Life in Patients With Bladder Cancer
OBJECTIVES: - To identify aspects of survivorship experience that differ by clinical risk (low risk vs high risk) in patients with non-invasive bladder cancer. - To collect and examine data …
Completed
Quality of Life and Symptom Management in Patients With Bladder Cancer
OBJECTIVES: Primary - To identify aspects of health-related quality of life (HRQOL) and symptom management in patients with non-invasive, low- or high-risk bladder cancer. - To obtain feedback on data …
Completed
Phase I/II Study of MK-0752 Followed by Docetaxel in Advanced or Metastatic Breast Cancer
Purpose—Accumulating evidence supports the existence of breast cancer stem cells (BCSCs), which are characterized by their capacity to self-renew and divide indefinitely, and resistance to conventional therapies. The Notch pathway …
Baylor Role: Collaborator
Completed
LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA)
Patients have an EBV-positive cancer. We had gotten permission to take blood from patients in the past, which was used to grow T cells in the laboratory. We first grew …
Baylor Role: Lead Sponsor
Withdrawn
Study of LMP1- and LMP2- Specific Cytotoxic T-Lymphocytes (CTL)
While patients with nasopharyngeal carcinoma (NPC) may be cured by chemotherapy and radiotherapy, the outlook for patients who are resistant to this treatment or who relapse is poor. Almost all …
Baylor Role: Lead Sponsor
Completed
Bladder Cancer Patient-Reported Outcomes
The purpose of this study is to identify aspects of the bladder cancer (BlCa) survivorship experience that differ by clinical risk at diagnosis. The investigators will collect cross-sectional data from …
Baylor Role: Lead Sponsor